Latham & Watkins LLP represented Invetx in the transaction. Invetx, a pioneer in protein-based therapeutics for animal health, has raised an additional US$10.25 million in its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
